U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Dr. Reed Tuckson: Vaccines and the Role ofMonoclonal Antibody Treatment

VIDEOS ON MONOCLONAL ANTIBODIES
 

Video Icon FEATURED VIDEO

Vaccines and the Role of Monoclonal Antibody Treatment
Dr. Reed Tuckson, founding member of the Black Coalition Against COVID 19, discusses how clinicians should counsel their patients regarding vaccination and monoclonal antibody (mAb) treatment.


LEARN MORE ABOUT mAbs

Watch the videos below for tips on counseling your COVID-19 patients about mAb treatments.

Lessons Learned: Monoclonal Antibody Treatment for COVID-19

LESSONS LEARNED: MONOCLONAL ANTIBODY TREATMENT FOR COVID-19

Clinicians and healthcare providers discuss what they learned throughout theCOVID-19 pandemic and their advice for healthcare providers as they continue to treat high-risk patients.

Improved Patient Outcomes: Monoclonal Antibody Treatment for COVID-19

IMPROVED PATIENT OUTCOMES: MONOCLONAL ANTIBODY TREATMENT FOR COVID-19

Clinicians and healthcare providers discuss the challenges they faced at the on set of the COVID-19 pandemic and the role monoclonal antibody treatment played in improving outcomes for their high-risk patients.

Treating High-Risk COVID-19 Patients with Monoclonal Antibodies

TREATING HIGH-RISK COVID-19 PATIENTS WITH MONOCLONAL ANTIBODIES

In this video you’ll learn more about mAbs, how they can be used to treat your high-risk COVID-19 patients, and how you can find treatment centers near you.


PROVIDER EXPERIENCES

In these short videos, providers from different settings discuss how they have increased patient access to mAb treatment.

Community Outreach for Monoclonal Antibody Treatment

COMMUNITY OUTREACH FOR MONOCLONAL ANTIBODY TREATMENT

Dr. Theresa Cullen, Public Health Director for Pima County, Arizona, discusses how she worked to make monoclonal antibody treatment for COVID-19 available to high-risk populations in her community.

Dr. Jennifer Tuteur: The Importance of Equitable Access to Monoclonal Antibodies forCOVID-19

DR. JENNIFER TUTEUR: THE IMPORTANCE OF EQUITABLE ACCESS TO MONOCLONAL ANTIBODIES FORCOVID-19

Dr. Jennifer Tuteur, Deputy Chief Medical Officer for San Diego County, discusses the critical role monoclonal antibody treatment plays in treating high-risk COVID-19 patients and strategies for reaching vulnerable populations in her community.

Dr. Mary Dittrich: Administering Monoclonal Antibodies to High-Risk COVID-19 Patients

DR. MARY DITTRICH: ADMINISTERING MONOCLONAL ANTIBODIES TO HIGH-RISK COVID-19 PATIENTS

Dr. Mary Dittrich, Chief Medical Officer for U.S. Renal Care, discusses how she set up infusion centers in dialysis centers to ensure high-risk patients received timely access to mAb treatment.

Grand View and TriValley Primary Care - Community Collaboration to Administer Monoclonal Antibodies

GRAND VIEW AND TRIVALLEY PRIMARY CARE – COMMUNITY COLLABORATION TO ADMINISTER MONOCLONAL ANTIBODIES

Grand View Health pharmacists and primary care physicians from Grand View Medical and TriValley Primary Care discuss how they brokered powerful partnerships in their community to ensure high-risk COVID-19 patients received mAb treatment.

Drs. Karen Murphy & Keith Boell: Monoclonal Antibody Treatment in a Health System Setting

DRS. KAREN MURPHY & KEITH BOELL: MONOCLONAL ANTIBODY TREATMENT IN A HEALTH SYSTEM SETTING

Drs. Karen Murphy and Keith Boell discuss their people-first approach to community health and the proactive measures they took to identify and counsel high-risk COVID-19 patients regarding mAbs as a treatment option.

Equitable Access to Monoclonal Antibody Treatmentfor COVID-19

DR. TERESE HAMMOND TESTIMONIAL – EQUITABLE ACCESS TO MONOCLONAL ANTIBODY TREATMENT

Dr. Terese Hammond, Program Medical Director at Providence Saint John's Health Center, discusses her efforts to ensure equitable access to mAb treatment for high-risk COVID-19 patients across Southern California.

Dr. Natalie McGann: Monoclonal Antibody Treatment in a Primary Practice Setting

DR. NATALIE MCGANN: MONOCLONAL ANTIBODY TREATMENT IN A PRIMARY PRACTICE SETTING

Dr. Natalie McGann of TriValley Primary Care discusses how they overcame obstacles to administer mAb treatments to high-risk COVID patients in a primary practice setting.

Dr. Gary Wiltz - Monoclonal Antibody Treatment Testimonial

DR. GARY M. WILTZ, CEO/CLINICAL CHO, TECHE ACTION CLINIC

Dr. Gary M. Wiltz, CEO/Clinical CHO, Teche Action Clinic, speaks about the challenges of treating COVID-19 patients in rural Southeast Louisiana. Together with local church leaders and TV and radio stations, he is trying to spread the word about the benefits of mAb treatment for high-risk COVID-19 patients.

Dr. Quinn and Colin Bander Testimonial

COLIN QUINN SPEAKS TO DR. JEFFREY BANDER

Stand-up comedian Colin Quinn (Saturday Night Live, Tough Crowd) speaks to Dr. Jeffrey Bander from Mount Sinai Hospital about how mAbs helped him recover from COVID-19.

Amy Hill - Monoclonal Antibodies Testimonial

AMY HILL TESTIMONIAL VIDEO

Filmmaker Amy Hill describes her experience with COVID-19 and how mAb treatment helped speed up her recovery.


EVENTS

The Future of Vaccines, Variants, and Treatment: The Vital Role of COVID-19 Monoclonal Antibodies

THE FUTURE OF VACCINES, VARIANTS, AND TREATMENT: THE VITAL ROLE OF COVID-19 MONOCLONAL ANTIBODIES

Watch Dr. John Redd of HHS and Dr. Lauri Hicks of CDC discuss the vital role COVID-19 monoclonal antibodies will play in the future of vaccines, variants, and treatment. Moderated by Dr. Adolphe Edward, CEO of El Centro Regional Medical Center.

Equitable Access to Monoclonal Antibody Treatment: Examples From Two States

EQUITABLE ACCESS TO MONOCLONAL ANTIBODY TREATMENT: EXAMPLES FROM TWO STATES

Watch Dr. Joneigh Khaldun (Chief Medical Executive for the State of Michigan and Chief Deputy Director for Health in the Michigan Department of Health and Human Services) and Dr. Howard Haft (Executive Director of the Maryland Primary Care Program) discuss their insights on equitable access to mAb treatment for high-risk COVID-19 patients in their respective states. Moderated by Ms. Cicely Waters (U.S. Department of Health and Human Services [HHS]/ Office of the Assistant Secretary for Preparedness and Response [ASPR]).

Dr. Michael Anderson on effectiveness of monoclonal antibodies | COVID-19 Update for June 24, 2021

WHAT PHYSICIANS NEED TO KNOW ABOUT MONOCLONAL ANTIBODIES

Watch a discussion with Dr. Michael Anderson, Senior Advisor at the HHS ASPR in Washington, D.C., about what physicians need to know about mAb treatments and their incredible effectiveness in helping certain patients avoid going to the hospital for COVID-19.

Discussion on Monoclonal Antibody Treatment with Dr. Vin Gupta and Dr. Robert Califf

PAST EVENT: DISCUSSION OF MONOCLONAL ANTIBODIES

The Facebook Live event featuring Dr. Vin Gupta and former U.S. Food and Drug Administration Commissioner Dr. Robert Califf is available for viewing at any time.

For more information, healthcare providers can visit the resources page.

NIH “A” Rating for mAbs

PAST EVENT: NIH “A” RATING FOR mAbs

Watch Dr. H. Clifford Lane (National Institutes of Health [NIH]) and Dr. Raj Gandhi (Harvard) discuss the updated recommendations on the use of mAbs released by the NIH COVID-19 Treatment Guidelines Panel in April 2021. Moderated by Ms. Cicely Waters (HHS/ASPR).


ADMINISTERING mAbs IN YOUR FACILITY

These videos are offered as resources to help you set up mAb infusions in your facility, learn more about mAb treatment, and increase awareness about its benefits.*

Speakers: Director of Oncology and Therapeutic Infusion Services Jenny Waltzer, Head Nurse Practitioner Lisa Kimbury, Nurse Marisa Marvin, and Infectious Diseases Clinical Pharmacist Victoria Adams.

Monoclonal Antibody Treatment: Patient Flow

MONOCLONAL ANTIBODY TREATMENT: PATIENT FLOW

First in a series from Mount Sinai Hospital in New York, describing the operations and set up of mAb infusion services. This video addresses the topic of optimizing efficiency and patient flow.

Monoclonal Antibody Treatment: Accountability and Safety

MONOCLONAL ANTIBODY TREATMENT: ACCOUNTABILITY AND SAFETY

Second in a series from Mount Sinai Hospital in New York, describing the operations and set up of mAb infusion services. This video addresses the topic of ensuring accountability and safety.

Monoclonal Antibody Treatment: Education Training

MONOCLONAL ANTIBODY TREATMENT: EDUCATION TRAINING

Third in a series from Mount Sinai Hospital in New York, describing the operations and set up of mAb infusion services. This video addresses the topic of managing education and training.

 

*Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government, and shall not be used for advertising or product endorsement purposes.